[{"address1": "10275 Science Center Dr.", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "212 433 3791", "website": "https://zentalis.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers in the United States. The company develops azenosertib, which is in a Phase 3 clinical trial for the treatment of ovarian cancer and other tumor types. It also develops ZN-c3-001, a phase 1 study that evaluated azenosertib monotherapy in solid tumors; and MAMMOTH (ZN-c3-006) is a Phase 1/2 clinical trial of azenosertib in patients with PARP-inhibitor resistant ovarian cancer. It has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC. Zentalis Pharmaceuticals, Inc. was incorporated in 2014 and is headquartered in San Diego, California.", "fullTimeEmployees": 166, "companyOfficers": [{"maxAge": 1, "name": "Ms. Julie M. Eastland M.B.A.", "age": 60, "title": "CEO, President & Director", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 397085, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Andrea  Paul J.D.", "age": 43, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 733005, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Vincent A. Vultaggio", "age": 40, "title": "SVP of Finance & Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Wendy  Chang", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. DiVasto P.E.", "age": 68, "title": "Senior Vice President of Technical Operations", "yearBorn": 1956, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ingmar  Bruns M.D., Ph.D.", "age": 49, "title": "Chief Medical Officer", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Haibo  Wang", "title": "Chief Business Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rajesh  Israni", "title": "Senior VP of Regulatory Affairs & Medical Writing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Henry  Gu", "title": "Senior VP & Head of Intellectual Property", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 8, "compensationRisk": 10, "shareHolderRightsRisk": 8, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.45, "open": 1.46, "dayLow": 1.415, "dayHigh": 1.5499, "regularMarketPreviousClose": 1.45, "regularMarketOpen": 1.46, "regularMarketDayLow": 1.415, "regularMarketDayHigh": 1.5499, "payoutRatio": 0.0, "beta": 1.716, "forwardPE": -0.40336138, "volume": 496777, "regularMarketVolume": 496777, "averageVolume": 939441, "averageVolume10days": 548290, "averageDailyVolume10Day": 548290, "bid": 1.42, "ask": 1.47, "bidSize": 1, "askSize": 1, "marketCap": 103875128, "fiftyTwoWeekLow": 1.01, "fiftyTwoWeekHigh": 5.44, "priceToSalesTrailing12Months": 3.8665597, "fiftyDayAverage": 1.3714, "twoHundredDayAverage": 2.078025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -190999328, "profitMargins": 0.0, "floatShares": 49794336, "sharesOutstanding": 72135504, "sharesShort": 4766727, "sharesShortPriorMonth": 5697118, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.066199996, "heldPercentInsiders": 0.13577, "heldPercentInstitutions": 0.81602997, "shortRatio": 3.37, "shortPercentOfFloat": 0.08270001, "impliedSharesOutstanding": 72135504, "bookValue": 4.73, "priceToBook": 0.30443975, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -224186000, "trailingEps": -2.28, "forwardEps": -3.57, "enterpriseToRevenue": -7.11, "enterpriseToEbitda": 0.958, "52WeekChange": -0.5231788, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 1.44, "targetHighPrice": 10.0, "targetLowPrice": 2.5, "targetMeanPrice": 6.1875, "targetMedianPrice": 5.5, "recommendationMean": 2.22222, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 332452992, "totalCashPerShare": 4.62, "ebitda": -199292992, "totalDebt": 42160000, "quickRatio": 6.726, "currentRatio": 6.937, "totalRevenue": 26865000, "debtToEquity": 14.273, "revenuePerShare": 0.377, "returnOnAssets": -0.26622, "returnOnEquity": -0.59454, "grossProfits": 26865000, "freeCashflow": -79273248, "operatingCashflow": -151522000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -7.4639897, "financialCurrency": "USD", "symbol": "ZNTL", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1585920600000, "postMarketChangePercent": 0.0, "postMarketPrice": 1.44, "postMarketChange": 0.0, "regularMarketChange": -0.00999999, "regularMarketDayRange": "1.415 - 1.5499", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 939441, "fiftyTwoWeekLowChange": 0.43000007, "fiftyTwoWeekLowChangePercent": 0.42574266, "fiftyTwoWeekRange": "1.01 - 5.44", "fiftyTwoWeekHighChange": -4.0, "fiftyTwoWeekHighChangePercent": -0.7352941, "fiftyTwoWeekChangePercent": -52.317883, "regularMarketChangePercent": -0.689654, "regularMarketPrice": 1.44, "shortName": "Zentalis Pharmaceuticals, Inc.", "longName": "Zentalis Pharmaceuticals, Inc.", "corporateActions": [], "postMarketTime": 1754683804, "regularMarketTime": 1754683200, "exchange": "NGM", "messageBoardId": "finmb_647536411", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1747253101, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754596800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -2.28, "epsForward": -3.57, "epsCurrentYear": -1.95714, "priceEpsCurrentYear": -0.73576754, "fiftyDayAverageChange": 0.06860006, "fiftyDayAverageChangePercent": 0.050021917, "twoHundredDayAverageChange": -0.63802505, "twoHundredDayAverageChangePercent": -0.30703434, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.2 - Buy", "cryptoTradeable": false, "displayName": "Zentalis Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]